352 results on '"Gris, J-C"'
Search Results
2. Reliability of hemostasis biomarkers is affected by time‐dependent intra‐patient variability
3. Evaluation of the non-compliance with grouping guidelines which may lead to “wrong blood in tube”, an observational study and risk factor analysis
4. Hemostasis parameters as prognostic biomarkers in gynecological cancer patients
5. Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
6. Intrauterine activation of the fetal immune system in response to maternal COVID-19
7. An impact of neutrophil extracellular traps to the prothrombotic state and tumor progression in gynecological cancer patients
8. Functioning of the ADAMTS-13/vWF axis and its clinical significance
9. Dysregulated platelet function in COVID-19 patients
10. Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial
11. Prognostic value of von Willebrand factor in clinical practice
12. Clinical significance of hemostasiological screening for thrombophilia in pregnant women with former thrombosis
13. Peripartum bleeding management in a patient with CalDAG‐GEFI deficiency
14. Features of the novel coronavirus infection in cancer patients
15. Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control study
16. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies
17. Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19
18. Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
19. Neutrophil extracellular traps: a role in inflammation and dysregulated hemostasis as well as in patients with COVID-19 and severe obstetric pathology
20. Features of nervous system damage in antiphospholipid syndrome
21. Catastrophic antiphospholipid syndrome and thromboses
22. Obstetric antiphospholipid syndrome: early LMWH-induced variations of angiogenic factors predict placenta-mediated pregnancy complications: OR188
23. Obstetric antiphospholipid syndrome: early lmwh-induced variations of angiogenic factors predict pregnancy loss: OR190
24. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
25. Association of the FTO gene with obesity and the metabolic syndrome is independent of the IRS-2 gene in the female population of Southern France
26. Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
27. Simple coagulation tests improve survival prediction in patients with septic shock
28. Does the type of fluid affect rapidity of shock reversal in an anaesthetized-piglet model of near-fatal controlled haemorrhage? A randomized study
29. The hidden activism of the misnamed
30. Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state.
31. Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
32. Simple coagulation tests improve early mortality prediction for patients in intensive care units who have proven or suspected septic shock
33. Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy
34. Antiphospholipid syndrome and pregnancy
35. Incidence of pregnancy outcomes in women with pregnancy loss subtypes bearing Leiden polymorphisms:comparison with the purely obstetric antiphospholipid syndrome: PB 4.66–3
36. Impact on the initial pregnancy loss subtype on pregnancy outcomes in the conventionally treated purely obstetric antiphospholipid syndrome: PB 4.65–1
37. Incidence of pregnancy outcomes in the conventionally treated purely obstetric antiphospholipid syndrome, pregnancy loss subtype: the NOH-APS observational study: PB 3.65–2
38. Circulating nucleosomes and plasma free DNA are increased in abnormal pregnancies: PB 2.66–2
39. Heparin promotes soluble vascular enothelial growth factor receptor expression in human placental villi: a rebuttal
40. Enoxaparin for the secondary prevention of placental vascular complications in women with previous severe pre-eclampsia: the pilot randomised controlled NOH-PE study: O-TH-095
41. Genetic variability of LXRbeta gene might contribute to preeclampsia: O-TH-094
42. Low molecular weight heparin for the secondary prevention of placental-mediated pregnancy complications: a systematic review and meta analysis: O-TH-091
43. Observational study of the various antiphospholipid antibodies-related deep venous thrombotic risk in women with an obstetrical antiphospholipid syndrome: O-WE-031
44. ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay
45. Laboratory monitoring of COVID-19 patients and importance of coagulopathy markers
46. Novel coronavirus infection (COVID-19) and risk groups in obstetrics and gynecology
47. Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state
48. Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels
49. Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis
50. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.